Chapters

Transcript

Video

Many dermatologists who observe and report excellent efficacy and tolerability with dupilumab also are asking: “How long should treatment be continued?” Can you provide guidance on this commonly asked question and on the safety profile?

Many dermatologists who observe and report excellent efficacy and tolerability with dupilumab also are asking: “How long should treatment be continued?” Can you provide guidance on this commonly asked question and on the safety profile?


Created by

CMEducation Resources iQ&A Case-By-Case Atopic Dermatitis Medical Intelligence Zone

Presenter

Peter Lio, MD

Peter Lio, MD

Clinical Assistant Professor of Dermatology and Pediatrics
Feinberg School of Medicine
Northwestern University
Chicago, Illinois